NHS gender-affirming care in the UK currently involves waiting lists that commonly run to five years or more before a first appointment, and longer before any prescription is issued. Private providers such as GenderGP and GenderCare can begin assessment within weeks and prescribe within months, though costs vary widely. Shared care arrangements with a GP can reduce ongoing private fees considerably.
What is the NHS pathway and how long does it actually take?
The NHS route begins with a referral, usually from a GP, to a Gender Dysphoria Clinic (GDC). There are a small number of these across England, with equivalent services in Scotland, Wales, and Northern Ireland. The principle is sound: specialist assessment, multi-disciplinary support, and access to hormones, surgery referrals, and ongoing care, all on the NHS. The reality, for most people right now, is a wait measured in years rather than months.
Published waiting times for NHS GDCs have at various points exceeded five years for a first appointment. People referred today are routinely told they should not expect to be seen within the next several years. Once seen, further appointments, assessments, and prescribing decisions add more time. People I have spoken to over the years describe a process that can feel designed to outlast their patience rather than support their health. That is not what the people working inside it intend, but it is the lived experience of the waiting list.
There is also the question of what happens once you are seen. NHS GDCs vary in their approach, and some people find the assessment process lengthy and at times intrusive. The pathway is improving in places, and the move towards primary care-based prescribing through the new Gender Incongruence services in some areas is a welcome shift in principle, though those services are not yet available everywhere and have their own waiting lists.
What do private providers offer, and how fast can they move?
Private gender care providers in the UK operate outside the NHS system, which means they are not bound by the same referral and waiting-list structures. The most prominent names are GenderGP, GenderCare, and a number of individual consultants and psychiatrists who specialise in this area. Each has a different model.
GenderGP, founded by me and now operating independently, uses an informed consent model. People can complete an initial health questionnaire and speak to a clinician relatively quickly. The timeline from first contact to having a prescription in hand has, for many people, been a matter of weeks to a few months rather than years. It operates largely online and serves people across the UK and internationally.
GenderCare is a consortium of individual specialists, including psychiatrists, endocrinologists, and other clinicians, who carry out private assessments and issue letters or referrals. Their model is more assessment-focused, which some people prefer and others find unnecessary. Waiting times vary by clinician; some are available within weeks, others have their own backlogs.
Several private psychiatrists and psychologists also offer gender assessments independently, and some GPs with an interest in this area will prescribe privately. The landscape is not fixed, and availability shifts.
What does private gender-affirming care cost in the UK?
Costs vary enough that any single figure would mislead you. What follows is a realistic shape rather than a quoted price, because fees change and different providers have different structures.
For an initial assessment with a private specialist, costs have typically ranged from around £150 to £500 or more, depending on the clinician's background, the length of the appointment, and what the assessment involves. A psychiatrist who writes a formal diagnostic letter for gender dysphoria will generally charge more than a general assessment with a nurse prescriber or GP.
For an ongoing subscription or monitoring model, such as GenderGP's, monthly fees have typically sat in the range of £25 to £75 per month depending on the tier of service. That covers prescription management and access to the clinical team. The medication itself is an additional cost on top, unless it is picked up by your GP through shared care.
Private prescriptions for hormones are not cheap when dispensed privately. Oestrogen patches, gel, or tablets for trans women, and testosterone gel or injections for trans men, can run to £30 to £100 or more per month at full private prescription cost, depending on the formulation and the pharmacy. Injectable testosterone tends to be on the lower end of the cost range per dose, though the frequency of injections affects the total.
Injectable oestrogen deserves a specific note here. Many trans women prefer injectable oestrogen, either oestradiol valerate or oestradiol cypionate, because it delivers stable blood levels and avoids the daily or twice-daily routine of gel or patches. Private prescriptions for injectables are accessible through providers like GenderGP, but they are harder to source in some pharmacies and have at times faced supply issues. If this is something you are considering, it is worth asking a provider directly about current availability and cost before factoring it into your planning.
What is shared care and how much can it save?
Shared care is an arrangement where a private provider issues the initial prescription and manages clinical oversight, but a NHS GP agrees to take over the day-to-day prescribing. This means your GP writes the NHS prescription, which is dispensed at standard prescription charge (currently £9.90 per item in England, free in Scotland, Wales, and Northern Ireland, and free for anyone with a prepayment certificate or an exemption).
For someone on ongoing hormone therapy, shared care can cut the monthly medication cost to almost nothing. The catch is that not every GP will agree to it. NHS England guidance on shared care for gender-affirming hormones has improved in recent years, and NHS GPs are encouraged to accept shared care from recognised private providers, but some still decline, citing unfamiliarity, conscientious objection, or concern about their prescribing responsibilities.
If your GP refuses shared care, it is worth asking them to explain their reasons in writing, and worth asking whether there is another GP at the practice who might be willing. You can also register with a different GP. It is not a guaranteed solution, but a significant number of people do successfully access NHS prescribing this way, which reduces their ongoing private costs to the monitoring subscription fee alone.
How do costs and timelines compare end to end?
If you stay entirely within the NHS system and join a waiting list today, you should expect to wait several years before you receive your first appointment, and further time beyond that before any prescription. The total cost to you as a patient is minimal, but the cost in time, in waiting through an unwanted puberty, in years of dysphoria unaddressed, is real and serious. Delay is not a neutral outcome, and the consequences fall on the person waiting.
If you go private, you could have an initial consultation within days to weeks, a prescription within weeks to a few months, and be on hormones within three to four months of starting the process, sometimes faster. The financial cost in year one, including assessment, subscription, and medication, might range from a few hundred pounds to well over a thousand, depending on the provider, the formulation, and whether you can access shared care. If shared care works, year two and beyond can drop significantly in cost, sometimes to just the monitoring subscription.
For people who cannot afford private care, the NHS route remains the only realistic option, and I do not want to be dismissive of that. Some people also find the structured NHS assessment process helpful. But for those who can access private care, even with difficulty, the evidence from the people I have spoken to is consistent: getting treatment sooner, and reducing the years spent waiting, makes a meaningful difference to wellbeing.
Can you be on a NHS waiting list and see a private provider at the same time?
Yes, and many people do exactly this. There is nothing to stop you staying on an NHS waiting list while accessing private care. If you are eventually seen by an NHS GDC, they will ask about your current medications and history, and most will continue prescribing from where a private provider has left off rather than requiring you to start over. That is not guaranteed and may depend on the clinic, but it is the more common experience.
Some people stay on the NHS list as a safety net, particularly if their financial situation might change, or because they want eventual access to NHS surgical pathways, which typically still require NHS referral and may require NHS clinical oversight at some stage.
What if your GP won't refer you in the first place?
A GP referral to an NHS GDC is not technically required: you can self-refer to most GDCs in England. In practice, having a GP involved makes the process smoother and gives you a local clinical record of your gender care. If your GP is refusing to refer you, that refusal should be explained to you, and you are entitled to ask for a second opinion or to register with a different practice. GPs cannot refuse a referral on the grounds that they disagree with gender-affirming care: that would be discriminatory under the Equality Act 2010.
If you want to go private, you do not need a GP referral at all. You approach the private provider directly.
Where should you start?
That depends on your circumstances, your urgency, and what you can afford. If you are in a position to access private care, GenderGP at gendergp.com is the provider I would point you to for starting or continuing medical transition. If you are weighing up the routes and working through what fits your situation, that is exactly the kind of thinking I am here for.
If there is a topic that you would like me to cover, just let Sammy know.
Written by Dr Helen Webberley, Gender Specialist and founder of GenderGP. Helen is an advocate for gender diversity and trans healthcare, and writes to help people navigate the systems and find the care they need.
Comments